Bridging the efficacy–effectiveness gap: a regulator's perspective on addressing variability of drug response
Published 2011 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Bridging the efficacy–effectiveness gap: a regulator's perspective on addressing variability of drug response
Authors
Keywords
-
Journal
NATURE REVIEWS DRUG DISCOVERY
Volume 10, Issue 7, Pages 495-506
Publisher
Springer Nature
Online
2011-07-01
DOI
10.1038/nrd3501
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- The ‘Wise List’- A Comprehensive Concept to Select, Communicate and Achieve Adherence to Recommendations of Essential Drugs in Ambulatory Care in Stockholm
- (2011) Lars L. Gustafsson et al. BASIC & CLINICAL PHARMACOLOGY & TOXICOLOGY
- An accelerated pathway for targeted cancer therapies
- (2011) Mark McClellan et al. NATURE REVIEWS DRUG DISCOVERY
- Pragmatic Trials — Guides to Better Patient Care?
- (2011) James H. Ware et al. NEW ENGLAND JOURNAL OF MEDICINE
- Patients with early rheumatoid arthritis who smoke are less likely to respond to treatment with methotrexate and tumor necrosis factor inhibitors: Observations from the Epidemiological Investigation of Rheumatoid Arthritis and the Swedish Rheumatology Reg
- (2010) Saedis Saevarsdottir et al. ARTHRITIS AND RHEUMATISM
- Body mass index and clinical response to infliximab in rheumatoid arthritis
- (2010) Ruth Klaasen et al. ARTHRITIS AND RHEUMATISM
- Clinical Pharmacology in Research, Teaching and Health Care
- (2010) Michael Orme et al. BASIC & CLINICAL PHARMACOLOGY & TOXICOLOGY
- Fruit juice inhibition of uptake transport: a new type of food-drug interaction
- (2010) David G. Bailey BRITISH JOURNAL OF CLINICAL PHARMACOLOGY
- Assessing the Clinical Utility of Diagnostics Used in Drug Therapy
- (2010) J Woodcock CLINICAL PHARMACOLOGY & THERAPEUTICS
- Enrichment of Clinical Study Populations
- (2010) R Temple CLINICAL PHARMACOLOGY & THERAPEUTICS
- Understanding Forgiveness: Minding and Mining the Gaps Between Pharmacokinetics and Therapeutics
- (2010) L G Osterberg et al. CLINICAL PHARMACOLOGY & THERAPEUTICS
- Public Pharmacovigilance Communication
- (2010) Priya Bahri DRUG SAFETY
- Relative effectiveness assessment of listed drugs (REAL): A new method for an early comparison of the effectiveness of approved health technologies
- (2010) Bruno Falissard et al. INTERNATIONAL JOURNAL OF TECHNOLOGY ASSESSMENT IN HEALTH CARE
- Effect of Concomitant CYP2D6 Inhibitor Use and Tamoxifen Adherence on Breast Cancer Recurrence in Early-Stage Breast Cancer
- (2010) Vincent O. Dezentjé et al. JOURNAL OF CLINICAL ONCOLOGY
- The Long and Winding Road to Warfarin Pharmacogenetic Testing**Editorials published in the Journal of the American College of Cardiologyreflect the views of the authors and do not necessarily represent the views of JACCor the American College of Cardiology.
- (2010) Geoffrey S. Ginsburg et al. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
- Self-titration for treatment of uncomplicated hypertension
- (2010) Gbenga Ogedegbe LANCET
- Mobile phones to improve HIV treatment adherence
- (2010) Benjamin H Chi et al. LANCET
- Effects of a mobile phone short message service on antiretroviral treatment adherence in Kenya (WelTel Kenya1): a randomised trial
- (2010) Richard T Lester et al. LANCET
- EBM, HTA, and CER: Clearing the Confusion
- (2010) BRYAN R. LUCE et al. MILBANK QUARTERLY
- 2009 FDA drug approvals
- (2010) Bethan Hughes NATURE REVIEWS DRUG DISCOVERY
- Personalized medicine in oncology: the future is now
- (2010) Richard L. Schilsky NATURE REVIEWS DRUG DISCOVERY
- New drug approval success rate in Europe in 2009
- (2010) Hans-Georg Eichler et al. NATURE REVIEWS DRUG DISCOVERY
- Integrating molecular diagnostics into anticancer drug discovery
- (2010) István Peták et al. NATURE REVIEWS DRUG DISCOVERY
- Accelerating the Use of Electronic Health Records in Physician Practices
- (2010) Steven Shea et al. NEW ENGLAND JOURNAL OF MEDICINE
- Thinking Outside the Pillbox — Medication Adherence as a Priority for Health Care Reform
- (2010) David M. Cutler et al. NEW ENGLAND JOURNAL OF MEDICINE
- Pharmacogenetics of Warfarin
- (2009) Farhad Kamali et al. Annual Review of Medicine
- Proposals for model-based paediatric medicinal development within the current European Union regulatory framework
- (2009) Efthymios Manolis et al. BRITISH JOURNAL OF CLINICAL PHARMACOLOGY
- A pragmatic-explanatory continuum indicator summary (PRECIS): a tool to help trial designers
- (2009) K. E. Thorpe et al. CANADIAN MEDICAL ASSOCIATION JOURNAL
- Pharmacogenomics: a new paradigm to personalize treatments in nephrology patients
- (2009) G. Zaza et al. CLINICAL AND EXPERIMENTAL IMMUNOLOGY
- SFINX—a drug-drug interaction database designed for clinical decision support systems
- (2009) Ylva Böttiger et al. EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY
- Genetic polymorphism of inosine-triphosphate-pyrophosphatase influences mercaptopurine metabolism and toxicity during treatment of acute lymphoblastic leukemia individualized for thiopurine-S-methyl-transferase status
- (2009) Gabriele Stocco et al. Expert Opinion On Drug Safety
- Pharmacogenetic testing of CYP2C9 and VKORC1 alleles for warfarin
- (2009) David A Flockhart et al. GENETICS IN MEDICINE
- Analysis of Drug Interactions Involving Fruit Beverages and Organic Anion-Transporting Polypeptides
- (2009) David J. Greenblatt JOURNAL OF CLINICAL PHARMACOLOGY
- How to reduce prescribing errors
- (2009) The Lancet LANCET
- Adjustment of dosing of antimicrobial agents for bodyweight in adults
- (2009) Matthew E Falagas et al. LANCET
- Rethinking therapeutic cancer vaccines
- (2009) NATURE REVIEWS DRUG DISCOVERY
- Gefitinib or Carboplatin–Paclitaxel in Pulmonary Adenocarcinoma
- (2009) Tony S. Mok et al. NEW ENGLAND JOURNAL OF MEDICINE
- A Comparison of Cost Effectiveness Using Data from Randomized Trials or Actual Clinical Practice: Selective Cox-2 Inhibitors as an Example
- (2009) Tjeerd-Pieter van Staa et al. PLOS MEDICINE
- Guidance for off-label use of drugs
- (2008) The Lancet Neurology LANCET NEUROLOGY
- Pharmacogenetics in drug discovery and development: a translational perspective
- (2008) Allen D. Roses NATURE REVIEWS DRUG DISCOVERY
- Balancing early market access to new drugs with the need for benefit/risk data: a mounting dilemma
- (2008) Hans-Georg Eichler et al. NATURE REVIEWS DRUG DISCOVERY
- More on Subgroup Analyses in Clinical Trials
- (2008) NEW ENGLAND JOURNAL OF MEDICINE
- A paucimorphic variant in the HMG-CoA reductase gene is associated with lipid-lowering response to statin treatment in diabetes: a GoDARTS study
- (2008) Louise A. Donnelly et al. Pharmacogenetics and Genomics
- Off-label drug use among hospitalised children: identifying areas with the highest need for research
- (2008) Linda Hsien et al. PHARMACY WORLD & SCIENCE
- Initial Severity and Antidepressant Benefits: A Meta-Analysis of Data Submitted to the Food and Drug Administration
- (2008) Irving Kirsch et al. PLOS MEDICINE
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreFind the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
Search